Dr. Flavia V. Castelino

Rheumatology
40 2nd Ave, 
Waltham, MA 
Accepting New Patients
Offers Telehealth
40 2nd Ave, 
Waltham, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Flavia Castelino is a Rheumatologist in Waltham, Massachusetts. Dr. Castelino is rated as an Experienced provider by MediFind in the treatment of Palindromic Rheumatism. Her top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Scleroma, and Sjogren Syndrome. Dr. Castelino is currently accepting new patients.

Her clinical research consists of co-authoring 46 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Internal Medicine in MA
Hospital Affiliations
Newton-Wellesley Hospital
Massachusetts General Hospital
North Shore Medical Center -
Cooley Dickinson Hospital Inc,the
Brigham And Women's Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

THE GENERAL HOSPITAL CORPORATION
40 2nd Ave, Waltham, MA 02451
Other Locations
THE GENERAL HOSPITAL CORPORATION
55 Fruit St, Boston, MA 02114

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Ifetroban in Patients With Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension (SSc-PAH)
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Ifetroban in Patients With Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension (SSc-PAH)
Enrollment Status: Active_not_recruiting
Publish Date: July 10, 2025
Intervention Type: Drug
Study Drug: Ifetroban
Study Phase: Phase 2
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Randomized, Placebo-controlled, Double-blind, Open-label Extension Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil (KD025) in Subjects With Diffuse Cutaneous Systemic Sclerosis
A Phase 2, Randomized, Placebo-controlled, Double-blind, Open-label Extension Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil (KD025) in Subjects With Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: August 30, 2023
Intervention Type: Drug
Study Drug: Belumosudil (KD025)
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: March 29, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Enrollment Status: Completed
Publish Date: February 17, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

46 Total Publications

Type III and type VI collagen neoepitopes are associated with disease severity in systemic sclerosis.
Type III and type VI collagen neoepitopes are associated with disease severity in systemic sclerosis.
Journal: The Journal of rheumatology
Published: November 15, 2025
Similar Doctors
Distinguished in Palindromic Rheumatism
Dr. Hoke H. Shirley
Rheumatology
Distinguished in Palindromic Rheumatism
Dr. Hoke H. Shirley
Rheumatology

Concord Hospital Inc

246 Pleasant St, Suite 210, 
Concord, NH 
 (57.5 miles away)
603-789-9101
Languages Spoken:
English
See accepted insurances

Hoke Shirley is a Rheumatologist in Concord, New Hampshire. Dr. Shirley is rated as a Distinguished provider by MediFind in the treatment of Palindromic Rheumatism. His top areas of expertise are Ankylosing Vertebral Hyperostosis with Tylosis, Behcet Disease, Temporal Arteritis, and Diffuse Idiopathic Skeletal Hyperostosis.

Advanced in Palindromic Rheumatism
Dr. Robert A. Kalish
Rheumatology
Advanced in Palindromic Rheumatism
Dr. Robert A. Kalish
Rheumatology

Pratt Medical Group Inc

800 Washigton St, 
Boston, MA 
 (10.7 miles away)
617-636-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Robert Kalish is a Rheumatologist in Boston, Massachusetts. Dr. Kalish is rated as a Distinguished provider by MediFind in the treatment of Palindromic Rheumatism. His top areas of expertise are Fibromyalgia, Rheumatoid Arthritis (RA), Scleroma, and Scleroderma. Dr. Kalish is currently accepting new patients.

Advanced in Palindromic Rheumatism
Dr. Jennifer M. Nashel
Rheumatology
Advanced in Palindromic Rheumatism
Dr. Jennifer M. Nashel
Rheumatology

Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc

1 Deaconess Rd, 
Boston, MA 
 (8.9 miles away)
781-983-9088
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jennifer Nashel is a Rheumatologist in Boston, Massachusetts. Dr. Nashel is rated as an Advanced provider by MediFind in the treatment of Palindromic Rheumatism. Her top areas of expertise are Gout, Relapsing Polychondritis, Scleroderma, and Scleroma. Dr. Nashel is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Castelino's expertise for a condition
ConditionClose
View All 13 Advanced Conditions
View All 34 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile